k-RAS mutations in non-small cell lung cancer patients treated with TKIs among smokers and non-smokers: a meta-analysis

AIM OF THE STUDY: Recent studies have suggested that k-RAS mutations are related to the response to epidermal growth factor receptor (EGFR) tyrosine-kinase inhibitions (TKIs) in advanced non-small cell lung cancer (NSCLC) treatment. The aim of this meta-analysis was to assess the relationship betwee...

Descripción completa

Detalles Bibliográficos
Autores principales: Jiang, Ai-Gui, Lu, Hui-Yu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Termedia Publishing House 2016
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4925733/
https://www.ncbi.nlm.nih.gov/pubmed/27358590
http://dx.doi.org/10.5114/wo.2016.60068

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4925733/
https://www.ncbi.nlm.nih.gov/pubmed/27358590
http://dx.doi.org/10.5114/wo.2016.60068

Ejemplares similares